Search Results - "Kaymaz‐Tahra, Sema"
-
1
Development of the Takayasu Arteritis Integrated Disease Activity Index
Published in Arthritis care & research (2010) (01-04-2024)“…Objective Accurate clinical assessment of disease activity in Takayasu arteritis (TAK) can be challenging. 18F‐fluorodeoxyglucose–positron emission tomography…”
Get full text
Journal Article -
2
HADS-depression score is a mediator for illness perception and daily life impairment in Takayasu’s arteritis
Published in Clinical rheumatology (01-10-2021)“…Introduction/objectives The aim of this study was to evaluate the relationships among the disease activity, illness perception, daily life performance, anxiety…”
Get full text
Journal Article -
3
Metabolic syndrome is associated with increased cardiovascular risk and disease damage in patients with Takayasu arteritis
Published in International journal of rheumatic diseases (01-07-2022)“…Objective Metabolic syndrome (MetS) is one of the preventable risk factors for cardiovascular disease (CVD). The aim of this study was to investigate the…”
Get full text
Journal Article -
4
Pregnancy in Takayasu’s arteritis has a high risk of hypertension‐related fetomaternal complications: A retrospective study of a Turkish cohort
Published in International journal of rheumatic diseases (01-02-2022)“…Background This study aimed to examine fetomaternal outcomes in pregnant women in a large Turkish Takayasu arteritis (TAK) cohort and to evaluate the effects…”
Get full text
Journal Article -
5
Identification of susceptibility loci for Takayasu arteritis through a large multi-ancestral genome-wide association study
Published in American journal of human genetics (07-01-2021)“…Takayasu arteritis is a rare inflammatory disease of large arteries. We performed a genetic study in Takayasu arteritis comprising 6,670 individuals (1,226…”
Get full text
Journal Article -
6
Certolizumab pegol in the treatment of Takayasu arteritis
Published in Rheumatology (Oxford, England) (01-12-2018)“…Abstract Objectives Certolizumab pegol (CZP) is a PEGylated antigen-binding fragment-fragment of a humanized mAb neutralizing TNF. It lacks Fc-fragment and has…”
Get full text
Journal Article -
7
Biologic treatments in Takayasu's Arteritis: A comparative study of tumor necrosis factor inhibitors and tocilizumab
Published in Seminars in arthritis and rheumatism (01-12-2021)“…To compare the treatment outcomes of TNF inhibitors and tocilizumab (TCZ) in patients with Takayasu arteritis. Takayasu arteritis patients who were refractory…”
Get full text
Journal Article -
8
Disease activity and prognosis in Takayasu’s arteritis
Published in Journal of Turkish Society for Rheumatology (01-12-2022)“…Assessment of disease activity has a critical role in the follow-up of Takayasu’s arteritis (TAK). However, disease activity indices that have been developed…”
Get full text
Journal Article -
9
Assessment of Takayasu arteritis in routine practice with PETVAS, an 18F-FDG PET quantitative scoring tool
Published in Turkish journal of medical sciences (01-04-2022)“…The aim of this study was to evaluate the value of the PET vascular activity score (PETVAS) during the follow-up of patients with Takayasu arteritis. Takayasu…”
Get full text
Journal Article -
10
Assessment of damage in Takayasu's arteritis
Published in Seminars in arthritis and rheumatism (01-08-2020)“…To assess the progression and the factors associated with damage in Takayasu's arteritis (TAK) patients during routine follow-up. Patients diagnosed with TAK…”
Get full text
Journal Article -
11
Assessment of damage in Takayasu‘s arteritis
Published in Seminars in arthritis and rheumatism (01-08-2020)“…To assess the progression and the factors associated with damage in Takayasu‘s arteritis (TAK) patients during routine follow-up. Patients diagnosed with TAK…”
Get full text
Journal Article -
12
Disease activity and prognosis in Takayasu's arteritis/ Takayasu arteritinde aktivite degerlendirmesi ve prognoz
Published in Journal of Turkish Society for Rheumatology (01-12-2022)“…Assessment of disease activity has a critical role in the follow-up of Takayasu's arteritis (TAK). However, disease activity indices that have been developed…”
Get full text
Journal Article -
13
-
14
Childhood-onset versus adult-onset Takayasu arteritis: A study of 141 patients from Turkey
Published in Seminars in arthritis and rheumatism (01-02-2021)“…To compare childhood-onset (c-TAK) versus adult-onset Takayasu arteritis (a-TAK) patients for vascular involvement, disease activity, damage, and treatment…”
Get full text
Journal Article -
15
Comparison of methotrexate and azathioprine as the first-line steroid-sparing immunosuppressive agents in patients with Takayasu's arteritis
Published in Seminars in arthritis and rheumatism (01-06-2024)“…Immunosuppressive (IS) agents are recommended for the first-line treatment of patients with active Takayasu's arteritis (TAK) together with glucocorticoids…”
Get full text
Journal Article -
16
257. CAN A ONE-HOUR QUANTITATIVE ASSESSMENT OF FDG-PET-CT (MODIFIED-PETVAS) BE USEFUL IN TAKAYASU’S ARTERITIS?
Published in Rheumatology (Oxford, England) (01-03-2019)Get full text
Journal Article -
17
Assessment of Takayasu arteritis in routine practice with PETVAS, an 18F-FDG PETquantitative scoring tool
Published in Turkish journal of medical sciences (01-01-2022)Get full text
Journal Article -
18
Frequency and the effects of spondyloarthritis-spectrum disorders on the clinical course and management of Takayasu arteritis: an observational retrospective study
Published in Clinical rheumatology (01-05-2024)“…Objectives Extravascular findings of Takayasu arteritis (TAK) often share features with the spondyloarthritis (SpA) spectrum of disorders. However, the…”
Get full text
Journal Article -
19
Hypogammaglobulinemia and severe infection risk in patients with autoimmune diseases during rituximab treatment
Published in Journal of Turkish Society for Rheumatology (27-11-2023)Get full text
Journal Article -
20
Hypogammaglobulinemia and severe infection risk in patients with autoimmune diseases during rituximab treatment/Otoimmun hastaligi olan hastalarda rituksimab tedavisi sirasinda hipogamaglobulinemi ve enfeksiyon riski
Published in Journal of Turkish Society for Rheumatology (01-11-2023)“…Objective: To assess the frequency and related factors of hypogammaglobulinemia (HGG) and severe infections in patients who received rituximab (RTX) for…”
Get full text
Journal Article